Quidel: Diagnostics Firm QuidelOrtho Contemplates Selling Transfusion Medicine Arm Valued Up To $2B: Report

QuidelOrtho Corp (NASDAQ: QDEL) is reportedly contemplating the potential sale of its transfusion medicine arm. The diagnostics company is currently collaborating with advisors to assess interest in this particular division, which is expected to attract attention from strategic and private equity investors. Also Read: Mixed Sentiment Persists Amid Uncertainty in QuidelOrtho's Core ...Full story available on Benzinga.com